Nothing has changed that we know of. For those long, the end game is near and all indications point towards good thing. This is just typical road bumps not uncommon to this stock and biotechs. Adam fraudstein can talk all he wants about the Manniacs that he seems to think worship Mann ( Adam never gives any examples which is very convenient for him) but it is Adam that is obsessed with Mann and mnkd.
The dust will clear and hopefully we will see afrezza approved and accepted by the diabetic community. And when that happens we cal all write to Adam to go skrew himself! :)
Yea this down day doesn't change the fact that I still believe in awesome data come August, eventual approval, and sales. My big bet was made many months ago and this one down day doesn't alter my exit strategy one bit.
It seems like a welcome opportunity if you were buying dips though :]
Nobody with any sense (or experience of the markets) can expect this or any stock to continue a rally indefinitely. They always retrace/correct, which over the long haul is a GOOD thing since it invites additional investors. This current dip is healthy for the long haul and was, in any case, a bit overdue. REALLY looking forward to late Spring and Summer.....